ASPERGILLOSIS

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN CHILDHOOD ASTHMA; A CASE REPORT

Authors

  • Javaria Rasheed Nishtar Hospital Multan.
  • Rushan Hassan Nishtar University Hospital Multan.
  • Muhammad Khalid Aga Khan University Hospital Karachi.
  • Fauzia Zafar Nishtar University Hospital Multan.

DOI:

https://doi.org/10.29309/TPMJ/2018.25.06.290

Keywords:

Allergic Bronchopulmonary Aspergillosis, Asthma, Children

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) is an illness caused by
hypersensitivity to colonized Aspergillus fumigatus, mostly involving susceptible adult patients
with history of asthma and cystic fibrosis. Timely given appropriate treatment can reduce
clinical symptoms, decrease lung infiltrates and stop progression to chronic lung disease. In
literature review, treatment strategies used in ABPA children are limited. Herein we present a
case of 10-year old asthmatic girl who, on developing ABPA, was successfully treated by the
use of low dose corticosteroids combined with itraconazole for 3 months duration. We suggest
that in financial constraint circumstances, ABPA in children can be successfully treated without
anti-IgE therapy.

Author Biographies

Javaria Rasheed, Nishtar Hospital Multan.

FCPS Pediatric Medicine
Senior Registrar
Pediatric Medicine Department Unit-1, 

Rushan Hassan, Nishtar University Hospital Multan.

Post Graduate Trainee,
Pediatric Medicine Department Unit-1, 

Muhammad Khalid, Aga Khan University Hospital Karachi.

FCPS Pediatric Medicine
Fellow Pediatric Infectious Diseases
Department,

Fauzia Zafar, Nishtar University Hospital Multan.

FCPS, DCH, MCPS
Professor & Head
Department of Pediatric Medicine

Downloads

Published

2018-06-10